Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parthasaradhireddy Tanguturi

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Frontiers in Pharmacology|March 20, 2023
The role of opioid receptors in modulating Alzheimer's DiseaseParthasaradhireddy Tanguturi, John M Streicher
Cancer Chemotherapy and Pharmacology|March 9, 2020
The role of deubiquitinating enzymes in cancer drug resistanceParthasaradhireddy Tanguturi, Kye-Seong Kim, Suresh Ramakrishna
Biochemical Genetics|February 2, 2013
Association between apolipoprotein E gene polymorphism and myocardial infarctionParthasaradhireddy Tanguturi, Bhoomireddy Pullareddy, P Sampath Kumar, et al.
Molecules (Basel, Switzerland)|November 13, 2021
Discovery of Novel Delta Opioid Receptor (DOR) Inverse Agonist and Irreversible (Non-Competitive) AntagonistsParthasaradhireddy Tanguturi, Vibha Pathak, Sixue Zhang, et al.
Molecules (Basel, Switzerland)|March 26, 2022
Correction: Tanguturi et al. Discovery of Novel Delta Opioid Receptor (DOR) Inverse Agonist and Irreversible (Non-Competitive) Antagonists. <i>Molecules</i> 2021, <i>26</i>, 6693Parthasaradhireddy Tanguturi, Vibha Pathak, Sixue Zhang, et al.
Molecules (Basel, Switzerland)|August 27, 2021
Synthesis and In Vitro Characterization of Glycopeptide Drug Candidates Related to PACAP<sub>1-23</sub>Christopher R Apostol, Parthasaradhireddy Tanguturi, Lajos Z Szabò, et al.
Pharmaceuticals (Basel, Switzerland)|October 29, 2025
Brain Hsp90 Inhibition Mitigates Facial Allodynia in a Rat Model of CSD Headache and Upregulates Endocannabinoid Signaling in the PAGSeph M Palomino, Aidan A Levine, Erika Liktor-Busa, et al.
International Journal of Molecular Sciences|January 21, 2022
Genome-Wide CRISPR/Cas9-Based Screening for Deubiquitinase Subfamily Identifies Ubiquitin-Specific Protease 11 as a Novel Regulator of Osteogenic DifferentiationKamini Kaushal, Apoorvi Tyagi, Janardhan Keshav Karapurkar, et al.
ACS Pharmacology & Translational Science|September 19, 2025
Development of Delta Opioid Receptor Antagonists Which Prevent Alzheimer's Disease-Like Pathology in the 5X-Familial Alzheimer's Disease [5XFAD] Mouse ModelParthasaradhireddy Tanguturi, Stefanie Mitchell, Omar Moukha-Chafiq, et al.
ACS Chemical Neuroscience|January 18, 2023
Design of Analgesic Trivalent Peptides with Low Withdrawal Symptoms: Probing the Antinociceptive Profile of Novel Linear and Cyclic Peptides as Opioid Pan LigandsAzzurra Stefanucci, Paola Minosi, Stefano Pieretti, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Frontiers in Pharmacology|March 20, 2023
The role of opioid receptors in modulating Alzheimer's DiseaseParthasaradhireddy Tanguturi, John M Streicher
Cancer Chemotherapy and Pharmacology|March 9, 2020
The role of deubiquitinating enzymes in cancer drug resistanceParthasaradhireddy Tanguturi, Kye-Seong Kim, Suresh Ramakrishna
Biochemical Genetics|February 2, 2013
Association between apolipoprotein E gene polymorphism and myocardial infarctionParthasaradhireddy Tanguturi, Bhoomireddy Pullareddy, P Sampath Kumar, et al.
Molecules (Basel, Switzerland)|November 13, 2021
Discovery of Novel Delta Opioid Receptor (DOR) Inverse Agonist and Irreversible (Non-Competitive) AntagonistsParthasaradhireddy Tanguturi, Vibha Pathak, Sixue Zhang, et al.
Molecules (Basel, Switzerland)|March 26, 2022
Correction: Tanguturi et al. Discovery of Novel Delta Opioid Receptor (DOR) Inverse Agonist and Irreversible (Non-Competitive) Antagonists. <i>Molecules</i> 2021, <i>26</i>, 6693Parthasaradhireddy Tanguturi, Vibha Pathak, Sixue Zhang, et al.
Molecules (Basel, Switzerland)|August 27, 2021
Synthesis and In Vitro Characterization of Glycopeptide Drug Candidates Related to PACAP<sub>1-23</sub>Christopher R Apostol, Parthasaradhireddy Tanguturi, Lajos Z Szabò, et al.
Pharmaceuticals (Basel, Switzerland)|October 29, 2025
Brain Hsp90 Inhibition Mitigates Facial Allodynia in a Rat Model of CSD Headache and Upregulates Endocannabinoid Signaling in the PAGSeph M Palomino, Aidan A Levine, Erika Liktor-Busa, et al.
International Journal of Molecular Sciences|January 21, 2022
Genome-Wide CRISPR/Cas9-Based Screening for Deubiquitinase Subfamily Identifies Ubiquitin-Specific Protease 11 as a Novel Regulator of Osteogenic DifferentiationKamini Kaushal, Apoorvi Tyagi, Janardhan Keshav Karapurkar, et al.
ACS Pharmacology & Translational Science|September 19, 2025
Development of Delta Opioid Receptor Antagonists Which Prevent Alzheimer's Disease-Like Pathology in the 5X-Familial Alzheimer's Disease [5XFAD] Mouse ModelParthasaradhireddy Tanguturi, Stefanie Mitchell, Omar Moukha-Chafiq, et al.
ACS Chemical Neuroscience|January 18, 2023
Design of Analgesic Trivalent Peptides with Low Withdrawal Symptoms: Probing the Antinociceptive Profile of Novel Linear and Cyclic Peptides as Opioid Pan LigandsAzzurra Stefanucci, Paola Minosi, Stefano Pieretti, et al.
Pageof 2